Health and life sciences
Scaling intelligent health in constrained systems
Health and life sciences organizations face a collision of pressures: rising costs, clinician shortages and aging populations, all while R&D teams race to accelerate pipelines without compromising safety. Legacy infrastructure, capacity constraints, and transformation fatigue keep ambition from becoming impact.
Yet the opportunity is real. Patients are more open than ever to digital care. Payers are accelerating the shift to outcome-based models. And AI, on stable foundations, can genuinely relieve the constraints holding the industry back.
To ensure their transformation is successful, health and life sciences organizations must align brand, experience, and technology as one system. AREA 17 helps you make that happen.
Read our full Health and life sciences market insights report here.
Health and life sciences index
-
Since 2025
-
Elevating patient care with AI
Since 2023 -
The space to invent
Since 2018 -
Advancing brain research through open science
2022–2024 -
System-level change through nature-centric design
2022–2024 -
Nanodiamond Biotechnologies
2023 -
The Lancet
2021–2022 -
Clarifying the complexity of foundational research
2020 -
Advancing our understanding of the brain
2020 -
Elsevier
2020 -
TNBC Foundation
2019 -
200 years of medical breakthroughs
2018–2019 -
A new kind of patient experience
2018 -
Advancing research in mathematics and the sciences
2017 -
Eurac Research
2012–2017 -
Biologically inspired engineering
2016 -
Human Grid
2013